Quantification of nortriptyline in plasma by HPLC and fluorescence detection

[EN] A simple, sensitive and specific high-performance liquid chromatography method has been developed for the determination of nortriptyline (NT) in plasma samples. The assay involved derivatization with 9H-fluoren-9-ylmethyl chloroformate (Fmoc-Cl) and isocratic reversed-phase (C-18) chromatograph...

ver descrição completa

Detalhes bibliográficos
Autores: Almudéver-Folch, Patricia|||0000-0003-3138-0862, Peris, José-Esteban, Garrigues, Teresa, Díez-Sales, Octavio, Melero, Ana, Alós, Manuel
Formato: artículo
Fecha de publicación:2010
País:España
Recursos:Universitat Politècnica de València (UPV)
Repositorio:RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Idioma:inglés
OAI Identifier:oai:riunet.upv.es:10251/202407
Acesso em linha:https://riunet.upv.es/handle/10251/202407
Access Level:acceso abierto
Palavra-chave:Derivatization
Fmoc chloride
Nortriptyline
HPLC
MICROBIOLOGIA
03.- Garantizar una vida saludable y promover el bienestar para todos y todas en todas las edades
Descrição
Resumo:[EN] A simple, sensitive and specific high-performance liquid chromatography method has been developed for the determination of nortriptyline (NT) in plasma samples. The assay involved derivatization with 9H-fluoren-9-ylmethyl chloroformate (Fmoc-Cl) and isocratic reversed-phase (C-18) chromatography with fluorescence detection. The developed method required only 100 mu l of plasma sample, deproteinized and derivatized in one step. Calibration curves were lineal over the concentration range of 5-5000 ng/ml. The derivatization reaction was performed at room temperature in 20 min and the obtained NT derivative was stable for at least 48 h at room temperature. The within-day and between-day relative standard deviation was below 8%. The limit of detection (LOD) was 2 ng/ml, and the lower limit of quantification (LLOQ) was established at 10 ng/ml. The method was applied on plasma collected from rats, at different time intervals, after intravenous administration of 0.5 mg of NT.